During the past decade, Hacettepe University Ihsan Dogramaci Children's Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hacettepe University Ihsan Dogramaci Children's Hospital" are "Sickle Cell Disease" (2 trials), "Vaso-occlusive Crisis" (2 trials), "Vaso-occlusive Pain Episode in Sickle Cell Disease" (2 trials) and "Biliary Atresia" (1 trials). Many other conditions were trialed in "Hacettepe University Ihsan Dogramaci Children's Hospital" in a lesser frequency.

Most popular intervention types in "Hacettepe University Ihsan Dogramaci Children's Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Inclacumab" (2 trials) and "Odevixibat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hacettepe University Ihsan Dogramaci Children's Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hacettepe University Ihsan Dogramaci Children's Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hacettepe University Ihsan Dogramaci Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hacettepe University Ihsan Dogramaci Children's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".